Assignee
NAT CENTRE FOR CELL SCIENCE
IN·4 granted patents·2 pending applications·1 citations·filing 2015–2022
Top patents by PatentIndex Score
6 records- 0155US2024408071A1Novel combination of serotonin receptor (5-htr2b) antagonist and an immunomodulator and chemotherapeutic drugs for inhibition of cancerNAT CENTRE FOR CELL SCIENCE·Filed 2022·Application pending·0 cites
- 0251US10429393B2Tumor deconstruction platform for the analysis of intra-tumor heterogeneityNAT CENTRE FOR CELL SCIENCE·Filed 2015·Granted Oct 1, 2019·1 cites·7 claims
- 0344US12023336B2Antiviral drug compounds and composition thereofNAT CENTRE FOR CELL SCIENCE·Filed 2019·Granted Jul 2, 2024·0 cites·10 claims
- 0444US11478532B2Therapeutic intervention for osteoporosisNAT CENTRE FOR CELL SCIENCE·Filed 2018·Granted Oct 25, 2022·0 cites·11 claims
- 0535US2022195012A1Daf-mcp chimeric proteins, process to manufacture the same and use of the chimeric protein for treating pathological conditions involving the complement systemNAT CENTRE FOR CELL SCIENCE·Filed 2020·Application pending·0 cites
- 0634US12544347B2Anti-cancer combination and a method of therapy using the combinationNAT CENTRE FOR CELL SCIENCE·Filed 2019·Granted Feb 10, 2026·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when NAT CENTRE FOR CELL SCIENCE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →